34 results on '"McDonald, Alison"'
Search Results
2. Using systematic data categorisation to quantify the types of data collected in clinical trials: the DataCat project
- Author
-
Crowley, Evelyn, Treweek, Shaun, Banister, Katie, Breeman, Suzanne, Constable, Lynda, Cotton, Seonaidh, Duncan, Anne, El Feky, Adel, Gardner, Heidi, Goodman, Kirsteen, Lanz, Doris, McDonald, Alison, Ogburn, Emma, Starr, Kath, Stevens, Natasha, Valente, Marie, and Fernie, Gordon
- Published
- 2020
- Full Text
- View/download PDF
3. The clinical and cost effectiveness of surgical interventions for stones in the lower pole of the kidney: the percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole kidney stones randomised controlled trial (PUrE RCT) protocol
- Author
-
McClinton, Sam, Starr, Kathryn, Thomas, Ruth, MacLennan, Graeme, Lam, Thomas, Hernandez, Rodolfo, Pickard, Robert, Anson, Ken, Clark, Terry, MacLennan, Steven, Thomas, David, Smith, Daron, Turney, Ben, McDonald, Alison, Cameron, Sarah, and Wiseman, Oliver
- Published
- 2020
- Full Text
- View/download PDF
4. Verifying participant-reported clinical outcomes: challenges and implications
- Author
-
Breeman, Suzanne, Constable, Lynda, Duncan, Anne, Starr, Kath, McDonald, Alison, Wileman, Samantha, and Cotton, Seonaidh
- Published
- 2020
- Full Text
- View/download PDF
5. TISU: Extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones: study protocol for a randomised controlled trial
- Author
-
McClinton, Samuel, Cameron, Sarah, Starr, Kathryn, Thomas, Ruth, MacLennan, Graeme, McDonald, Alison, Lam, Thomas, N’Dow, James, Kilonzo, Mary, Pickard, Robert, Anson, Ken, Keeley, Frank, Burgess, Neil, Clark, Charles Terry, MacLennan, Sara, Norrie, John, and for the TISU Study Group
- Published
- 2018
- Full Text
- View/download PDF
6. Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): study protocol for a randomised controlled trial
- Author
-
Constable, Lynda, Cotterill, Nikki, Cooper, David, Glazener, Cathryn, Drake, Marcus J., Forrest, Mark, Harding, Chris, Kilonzo, Mary, MacLennan, Graeme, McCormack, Kirsty, McDonald, Alison, Mundy, Anthony, Norrie, John, Pickard, Robert, Ramsay, Craig, Smith, Rebecca, Wileman, Samantha, Abrams, Paul, and (Chief Investigator) for the MASTER Study Group
- Published
- 2018
- Full Text
- View/download PDF
7. What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK
- Author
-
Duley, Lelia, Gillman, Alexa, Duggan, Marian, Belson, Stephanie, Knox, Jill, McDonald, Alison, Rawcliffe, Charlotte, Simon, Joanne, Sprosen, Tim, Watson, Jude, and Wood, Wendy
- Published
- 2018
- Full Text
- View/download PDF
8. A comparison of an objective and subjective test of stress urinary incontinence (SUI) and their acceptability to participants
- Author
-
Davidson, Tracey, McDonald, Alison, McPherson, Gladys, and Norrie, John
- Published
- 2015
- Full Text
- View/download PDF
9. Evaluating the use of real-time data collection using SMS texts in the SIMS study
- Author
-
Davidson, Tracey, McDonald, Alison, McPherson, Gladys, and Norrie, John
- Published
- 2015
- Full Text
- View/download PDF
10. Does size matter? Trial management strategies to increase response rates. The assessment of physical questionnaire size on response rates (APS) sub-study
- Author
-
Davidson, Tracey, McPherson, Gladys, McDonald, Alison, and Norrie, John
- Published
- 2015
- Full Text
- View/download PDF
11. Overcoming a trial ‘adverse event’: impact and experiences of a temporary suspension of randomisation in clinical trials
- Author
-
Constable, Lynda, Davidson, Tracey, Wileman, Samantha, McCormack, Kirsty, Thomas, Ruth, McDonald, Alison, Glazener, Cathryn, and Norrie, John
- Published
- 2015
- Full Text
- View/download PDF
12. Strategies to improve response rates to patient reported outcome measures in a surgical RCT
- Author
-
Wood, Jessica, Bruhn, Hanne, Cook, Jonathan A, McDonald, Alison, Norrie, John, and Watson, Angus J M
- Published
- 2015
- Full Text
- View/download PDF
13. Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals.
- Author
-
Mitchell, Eleanor, Goodman, Kirsteen, Hartley, Suzanne, Hickey, Helen, McDonald, Alison M., Meadows, Helen M., Rhodes, Shelley, Taylor, Jodi, Wakefield, Natalie, Farrell, Barbara, and UK Trial Managers’ Network Executive Group
- Subjects
CAREER development ,JOB titles ,CLINICAL trials ,COMPUTER surveys - Abstract
Background: Clinical trials commonly have a dedicated trial manager and effective trial management is essential to the successful delivery of high-quality trials. Trial managers have diverse experience and currently there is no standardised structured career pathway. The UK Trial Managers' Network (UKTMN) surveyed its members to understand what is important to them with respect to career development since this would be important in the development of any initiative intended to develop a skilled workforce.Methods: We conducted an online survey of UKTMN members, who are trial management professionals, working on academic-led trials in the UK. Members were asked what they perceive as opportunities and barriers to career development. Two reminders were sent to facilitate completion of the survey, and responders were offered the opportunity to enter a prize draw for waived fees at the UKTMN annual meeting. Data were analysed descriptively by using Stata (version 15.1), and free-text responses were reviewed for themes.Results: The survey was sent to 819 UKTMN members; 433 responses were received, although 13 were from non-UKTMN members; thus 420 respondents' data were included in analyses. Respondents were representative of UKTMN membership; however, more responses were received by trial managers based in registered clinical trials units (CTUs). The top three opportunities for career development were (i) training, (ii) helping design trials and (iii) undertaking relevant qualifications. The top three barriers were (i) funding, (ii) few opportunities to get involved in development activities aside from managing a trial and (iii) unclear organisational career pathway. Almost all respondents (401/420, 95.4%) considered career development either very or quite important. Although all respondents had a day-to-day role in managing trials, there was huge disparity between job titles.Conclusion: Career development is important to trial managers yet there is a lack of a structured pathway. The enablers and disablers to career development for trial managers should be clearly considered by the clinical trial community and, in particular, employers, sponsors and funders in order to develop a highly skilled workforce of trial managers, who are key to the delivery of trials. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
14. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial.
- Author
-
Cooper, Kevin, McCormack, Kirsty, Breeman, Suzanne, Wood, Jessica, Scott, Neil W., Clark, Justin, Hawe, Jed, Hawthorn, Robert, Phillips, Kevin, Hyde, Angela, McDonald, Alison, Forrest, Mark, Wileman, Samantha, Scotland, Graham, Norrie, John, Bhattacharya, Siladitya, and HEALTH Study Group
- Subjects
MENSTRUATION disorders ,DYSMENORRHEA ,GYNECOLOGY ,PRIMARY care ,HYSTERECTOMY ,PAIN management ,WOMEN - Abstract
Background: Heavy menstrual bleeding (HMB) is a common problem affecting approximately 1.5 million women in England and Wales with a major impact on their physical, emotional, social and material quality of life. It is the fourth most common reason why women attend gynaecology outpatient clinics and accounts for one-fifth of all gynaecology outpatient referrals. Initial treatment in primary care is medical - either by means of oral or injected medication or the levonorgestrel-intrauterine system (Mirena®). If medical treatment fails then surgical treatment can be offered, either endometrial ablation (EA), which destroys the lining of the cavity of the uterus (endometrium), or hysterectomy, i.e. surgical removal of the uterus. While effective, conventional hysterectomy is invasive and carries a risk of complications due to injury to other pelvic structures. The procedure can be simplified and complications minimised by undertaking a 'supracervical' hysterectomy where the cervix is left in situ and only the body of the uterus removed. Recent advances in endoscopic technologies have facilitated increased use of laparoscopic supracervical hysterectomy (LASH) which can be performed as a day-case procedure and is relatively easy for the surgeon to learn. HEALTH (Hysterectomy or Endometrial AbLation Trial for Heavy menstrual bleeding) aims to address the question 'Is LASH superior to second generation EA for the treatment of HMB in terms of clinical and cost effectiveness?'Methods/design: Women aged < 50 years, with HMB, in whom medical treatment has failed and who are eligible for EA will be considered for trial entry. We aim to recruit women from approximately 30 active secondary care centres in the UK NHS who carry out both surgical procedures. All women who consent will complete a diary of pain symptoms from day 1 to day 14 after surgery, postal questionnaires at six weeks and six months after surgery and 15 months post randomisation. Healthcare utilisation questions will also be completed at the six-week, six-month and 15-month time-points.Discussion: Measuring the comparative effectiveness of LASH vs EA will provide the robust evidence required to determine whether the new technique should be adopted widely in the NHS.Trial Registration: International Standard Randomised Controlled Trials, ISRCTN49013893 . Registered on 28 January 2014. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
15. THISTLE: trial of hands-on Interprofessional simulation training for local emergencies: a research protocol for a stepped-wedge clustered randomised controlled trial.
- Author
-
Lenguerrand, Erik, Winter, Catherine, Innes, Karen, MacLennan, Graeme, Siassakos, Dimitrios, Lynch, Pauline, Cameron, Alan, Crofts, Joanna, McDonald, Alison, McCormack, Kirsty, Forrest, Mark, Norrie, John, Bhattacharya, Siladitya, Draycott, Tim, and Thistle group
- Subjects
INTRAPARTUM care ,OBSTETRICAL emergencies ,APGAR score ,PREGNANCY complications ,MEDICAL emergencies ,LABOR complications (Obstetrics) ,COMPARATIVE studies ,EXPERIMENTAL design ,HEALTH care teams ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,EVALUATION research ,RANDOMIZED controlled trials ,THERAPEUTICS - Abstract
Background: Many adverse pregnancy outcomes in the UK could be prevented with better intrapartum care. Training for intrapartum emergencies has been widely recommended but there are conflicting data about their effectiveness. Observational studies have shown sustained local improvements in perinatal outcomes associated with the use of the PRactical Obstetric Multi-Professional Training - (PROMPT) training package. However this effect needs to be investigated in the context of randomised study design in settings other than enthusiastic early adopter single-centres. The main aim of this study is to determine the effectiveness of PROMPT to reduce the rate of term infants born with low APGAR scores.Methods: THISTLE (Trial of Hands-on Interprofessional Simulation Training for Local Emergencies) is a multi-centre stepped-wedge clustered randomised controlled superiority trial conducted across 12 large Maternity Units in Scotland. On the basis of prior observational findings all Units have been offered the intervention and have been randomly allocated in groups of four Units, to one of three intervention time periods, each six months apart. Teams of four multi-professional clinicians from each participating Unit attended a two-day PROMPT Train the Trainers (T3) programme prior to the start of their allocated intervention step. Following the T3 training, the teams commenced the implementation of local intrapartum emergency training in their own Units by the start of their allocated intervention period. Blinding has not been possible due to the nature of the intervention. The aim of the study is to follow up each Unit for at least 12-months after they have commenced their local courses. The primary outcome for the study is the proportion of Apgar scores <7 at 5 min for term vaginal or emergency caesarean section births (≥37 weeks) occurring in each of the study Units. These data will be extracted from the Information Services Division Scottish Morbidity Record 02, a national routine data collection on pregnancy and births. Mixed or marginal logistic regression will be employed for the main analysis.Discussion: THISTLE is the first stepped wedge cluster randomised trial to evaluate the effectiveness of an intrapartum emergencies training programme. The results will inform training, trainers and policy going forward.Trial Registration: ISRCTN11640515 (registered on 09/09/2013). [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
16. Two parallel, pragmatic, UK multicentre, randomised controlled trials comparing surgical options for upper compartment (vault or uterine) pelvic organ prolapse (the VUE Study): study protocol for a randomised controlled trial.
- Author
-
Glazener, Cathryn, Goulao, Beatriz, Breeman, Suzanne, McDonald, Alison, McPherson, Gladys, Norrie, John, Constable, Lynda, Hemming, Christine, Cooper, Kevin, Elders, Andrew, Hagen, Suzanne, Freeman, Robert, Smith, Anthony R. B., Montgomery, Isobel, Kilonzo, Mary, and Boyers, Dwayne
- Subjects
UTERINE prolapse ,HYSTERECTOMY ,UTERINE surgery ,SYMPTOMS ,RANDOMIZED controlled trials ,COMPARATIVE studies ,PELVIC organ prolapse ,EXPERIMENTAL design ,GYNECOLOGIC surgery ,LAPAROSCOPY ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH protocols ,QUALITY of life ,RESEARCH ,STATISTICAL sampling ,SURGICAL complications ,SUTURING ,TIME ,VAGINAL hysterectomy ,EVALUATION research ,TREATMENT effectiveness ,SURGICAL meshes ,DIAGNOSIS ,EQUIPMENT & supplies ,SURGERY - Abstract
Background: One in three women who have a prolapse operation will go on to have another operation, though not necessarily in the same compartment. Surgery can result in greater impairment of quality of life than the original prolapse itself (such as the development of new-onset urinary incontinence, or prolapse at a different site). Anterior and posterior prolapse surgery is most common (90 % of operations), but around 43 % of women also have a uterine (34 %) or vault (9 %) procedure at the same time. There is not enough evidence from randomised controlled trials (RCTs) to guide management of vault or uterine prolapse. The Vault or Uterine prolapse surgery Evaluation (VUE) study aims to assess the surgical management of upper compartment pelvic organ prolapse (POP) in terms of clinical effectiveness, cost-effectiveness and adverse events.Methods/design: VUE is two parallel, pragmatic, UK multicentre, RCTs (Uterine Trial and Vault Trial). Eligible for inclusion are women with vault or uterine prolapse: requiring a surgical procedure, suitable for randomisation and willing to be randomised. Randomisation will be computer-allocated separately for each trial, minimised on: requiring concomitant anterior and/or posterior POP surgery or not, concomitant incontinence surgery or not, age (under 60 years or 60 years and older) and surgeon. Participants will be randomly assigned, with equal probability to intervention or control arms in either the Uterine Trial or the Vault Trial. Uterine Trial participants will receive either a vaginal hysterectomy or a uterine preservation procedure. Vault Trial participants will receive either a vaginal sacrospinous fixation or an abdominal sacrocolpopexy. Participants will be followed up by postal questionnaires (6 months post surgery and 12 months post randomisation) and also reviewed in clinic 12 months post surgery. The primary outcome is the participant-reported Pelvic Organ Prolapse Symptom Score (POP-SS) at 12 months post randomisation.Discussion: Demonstrating the efficacy of vault and uterine prolapse surgeries is relevant not only to patients and clinicians but also to health care providers, both in the UK and globally.Trial Registration: Current controlled trials ISRCTN86784244 (assigned 19 October 2012), and the first subject was randomly assigned on 1 May 2013. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
17. A pragmatic, multicentre, randomised controlled trial comparing stapled haemorrhoidopexy to traditional excisional surgery for haemorrhoidal disease (eTHoS): study protocol for a randomised controlled trial.
- Author
-
Watson, Angus J. M., Bruhn, Hanne, MacLeod, Kathleen, McDonald, Alison, McPherson, Gladys, Kilonzo, Mary, Norrie, John, Loudon, Malcolm A., McCormack, Kirsty, Buckley, Brian, Brown, Steven, Curran, Finlay, Jayne, David, Rajagopal, Ramesh, and Cook, Jonathan A.
- Subjects
HEMORRHOIDS ,RANDOMIZED controlled trials ,MEDICAL economics ,LIGATURE (Surgery) ,QUALITY of life - Abstract
Background Current interventions for haemorrhoidal disease include traditional haemorrhoidectomy (TH) and stapled haemorrhoidopexy (SH) surgery. However, uncertainty remains as to how they compare from a clinical, quality of life (QoL) and economic perspective. The study is therefore designed to determine whether SH is more effective and more cost-effective, compared with TH. Methods/Design eTHoS (either Traditional Haemorrhoidectomy or Stapled Haemorrhoidopexy for Haemorrhoidal Disease) is a pragmatic, multicentre, randomised controlled trial. Currently, 29 secondary care centres are open to recruitment. Patients, aged 18 year or older, with circumferential haemorrhoids grade II to IV are eligible to take part. The primary outcomes include QoL profile (area under the curve derived from the EuroQol Group's 5 Dimension Health Status Questionnaire (EQ-5D) at all assessment points) and economic, incremental cost per quality adjusted life year (QALY) based on the responses to the EQ-5D at 24 months. The secondary outcomes include a comparison of the SF-36 scores, pain and symptoms sub-domains, disease recurrence, complication rates and direct and indirect costs to the National Health Service (NHS). A sample size of n =338 per group has been calculated to provide 90% power to detect a difference in the mean area under the quality of life curve (AUC) of 0.25 standard deviations derived from EQ-5D score measurements, with a twosided significance level of 5%. Allowing for non-response, 400 participants will be randomised per group. Randomisation will utilise a minimisation algorithm that incorporates centre, grade of haemorrhoidal disease, baseline EQ-5D score and gender. Blinding of participants and outcome assessors is not attempted. Discussion This is one of the largest trials of its kind. In the United Kingdom alone, 29,000 operations for haemorrhoidal disease are done annually. The trial is therefore designed to give robust evidence on which clinicians and health service managers can base management decisions and, more importantly, patients can make informed choices. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
18. Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an alpha-blocker (tamsulosin): study protocol for a randomized controlled trial
- Author
-
McClinton, Sam, Starr, Kathryn, Thomas, Ruth, McLennan, Graeme, McPherson, Gladys, McDonald, Alison, Lam, Thomas, ¿Dow, James N., Kilonzo, Mary, Pickard, Robert, Anson, Ken, and Burr, Jennifer
- Subjects
DRUG therapy ,HOSPITAL patients ,PLACEBOS ,NIFEDIPINE ,RANDOMIZED controlled trials - Abstract
Background Urinary stone disease is common, with an estimated prevalence among the general population of 2% to 3%. Ureteric stones can cause severe pain and have a significant impact on quality of life, accounting for over 15,000 hospital admissions in England annually. Uncomplicated cases of smaller stones in the lower ureter are traditionally treated expectantly. Those who fail standard care or develop complications undergo active treatment, such as extracorporeal shock wave lithotripsy or ureteroscopy with stone retrieval. Such interventions are expensive, require urological expertise and carry a risk of complications. Growing understanding of ureteric function and pathophysiology has led to the hypothesis that drugs causing relaxation of ureteric smooth muscle, such as the selective α-blocker tamsulosin and the calcium-channel blocker nifedipine, can enhance the spontaneous passage of ureteric stones. The use of drugs in augmenting stone passage, reducing the morbidity and costs associated with ureteric stone disease, is promising. However, the majority of clinical trials conducted to date have been small, poor to moderate quality and lacking in comprehensive economic evaluation. This trial aims to determine the clinical and cost-effectiveness of tamsulosin and nifedipine in the management of symptomatic urinary stones. Methods/design The SUSPEND (Spontaneous Urinary Stone Passage ENabled by Drugs) trial is a multicentre, double-blind, randomized controlled trial evaluating two medical expulsive therapy strategies (nifedipine or tamsulosin) versus placebo. Patients aged 18 to 65 with a ureteric stone confirmed by non-contrast computed tomography of the kidney, ureter and bladder will be randomized to receive nifedipine, tamsulosin or placebo (400 participants per arm) for a maximum of 28 days. The primary clinical outcome is spontaneous passage of ureteric stones at 4 weeks (defined as no further intervention required to facilitate stone passage). The primary economic outcome is a reduction in the incremental cost per quality-adjusted life years, determined at 12 weeks. The analysis will be based on all participants as randomized (intention to treat). The trial has 90% power with a type I error rate of 5% to detect a 10% increase in primary outcome between the tamsulosin and nifedipine treatment groups. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
19. Do advance telephone calls ahead of reminder questionnaires increase response rate in nonresponders compared to questionnaire reminders only? The RECORD phone trial.
- Author
-
MacLennan, Graeme, McDonald, Alison, McPherson, Gladys, Treweek, Shaun, and Avenell, Alison
- Subjects
- *
TELEPHONE calls , *RESPONSE rates , *RANDOMIZED controlled trials , *LOGISTIC regression analysis , *CONFIDENCE intervals - Abstract
Background Postal questionnaires are simple and economical for collecting outcome data for randomised controlled trials (RCTs) but are prone to non-response. In the RECORD trial (a large pragmatic publicly funded RCT in UK) non-responders were sent a reminder and another questionnaire at 1 year, of which 40% were returned. In subsequent years we investigated the effect of an advance telephone call to non-responders on responses rate to reminder questionnaires and the next questionnaire 4 months later. Methods Non-responders to annual questionnaires were randomised to receive a telephone call from the trial office ahead of the reminder questionnaire in addition to the usual reminder schedule (n = 390) or to a control group that received the usual reminder schedule only (n = 363). The primary outcome was response to the reminder questionnaire within 21 days; secondary outcomes were response to a questionnaire 4 months later; completeness of quality of life instruments; and the number of participants declining further follow-up. Results are presented as odds ratios from a logistic regression intention-to-treat (ITT) analysis and then percentage difference and 95% confidence intervals (CI) for both ITT and average treatment effect on the treated (ATT) analyses. Results The proportions that responded were 67.8% (265/390) in the intervention group compared to 62.5% (227/363) in the control group. The ITT estimate was a 5.4% increase (95% CI -1.4 to 12.2). Four months later percentages responding were 51.8% (202) and 42.7% (155). The ITT estimate was a 9.1% increase (95% CI 2.0 to 16.2). In the intervention group 12.3% (48/390) of participants were not telephoned because questionnaires were returned before the scheduled telephone call. ATT estimates adjusting for this were 6.2% (95% CI -1.6 to 14.0) and 10.4% (95% CI 2.2 to 18.5), respectively. Conclusions The telephone call resulted in a slight increase in response to the reminder questionnaire, however at 4 months later the proportion in the telephoned group responding was greater. This study suggests that pre-notification telephone calls may only be worthwhile if further questionnaires are to be sent out soon after reminder questionnaires. Trial registration Current Clinical Trials ISRCTN51647438 [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
20. Reflecting on the methodological challenges of recruiting to a United Kingdom-wide, multi-centre, randomised controlled trial in gynaecology outpatient settings.
- Author
-
Dickson, Sylvia, Logan, Janet, Hagen, Suzanne, Stark, Diane, Glazener, Cathryn, McDonald, Alison M., and McPherson, Gladys
- Subjects
GYNECOLOGY ,RANDOMIZED controlled trials ,PHYSIOLOGICAL therapeutics ,GYNECOLOGISTS ,CONTROL groups ,PRIMARY care ,CLINICAL trials - Abstract
Background Successful recruitment of participants to any trial is central to its success. Trial results are routinely published, and recruitment is often cited to be slower and more difficult than anticipated. This article reflects on the methodological challenges of recruiting women with prolapse attending United Kingdom (UK) gynaecology outpatient clinics to a multi-centre randomised controlled trial (RCT) of physiotherapy, and the systems put in place in an attempt to address them. Methods Gynaecology outpatients with symptomatic prolapse were to be recruited over a 16-month period from 14 UK hospitals and one New Zealand hospital. Eligible women were informed about the trial by their gynaecologist and informed consent was obtained by the central trial office. Recruitment difficulties were encountered early on, and a number of strategies were employed to try to improve recruitment. Results Some strategies were more successful than others and they differed in the resources required. Actions that facilitated recruitment included increasing recruiting centres to 23 UK and two international hospitals, good centre support, using processes embedded in clinical practice, and good communication between the trial office,collaborators and participants. Collaborator incentives, whereby staff involved received the benefit immediately, were more successful than a nominal monetary payment per woman randomised. Barriers to recruitment included fewer eligible women than anticipated, patient's preference to receive active treatment rather than allocation to the control group, lack of support staff and high staff turnover. Geographical variations in Primary Care Trust Research Management and Governance approval systems and general practitioner (GP) referral procedures also impacted negatively on recruitment. Conclusions Our article reflects on the methodological challenges of recruiting to a multi-centre RCT in a UK gynaecology setting. Effective interventions included increasing the number of recruiting centres and providing collaborator incentives. Barriers to recruitment included fewer eligible women than anticipated, patient's preference to be allocated to the treatment group, lack of support staff, and variations in approval systems and GP referral procedures. To improve the evidence base on clinical trial recruitment, trialists need to publish their experiences and lessons learned. Future RCTs should evaluate, where possible, the effect of strategies designed to improve recruitment and retention. Trial registration Current Controlled Trials ISRCTN35911035. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
21. Single port/incision laparoscopic surgery compared with standard three-port laparoscopic surgery for appendicectomy - a randomised controlled trial.
- Author
-
Malik, Momin, McCormack, Kirsty, Krukowski, Zygmunt H., McDonald, Alison, McPherson, Gladys, Cook, Jonathan A., and Ahmed, Irfan
- Subjects
LAPAROSCOPIC surgery ,CLINICAL trials ,POSTOPERATIVE care ,APPENDIX diseases ,HOSPITAL admission & discharge - Abstract
Background: Laparoscopic surgery has become the preferred approach for many procedures because of reduced post-operative pain, better recovery, shorter hospital stay and improved cosmesis. Single incision laparoscopic surgery is one of the many recent variants where either standard ports or a specially designed single multi-channel port is introduced through a single skin incision. While the cosmetic advantage of this is obvious, the evidence base for claims of reduced morbidity and better post-operative recovery is weak. This study aims to compare the effectiveness of single port/incision laparoscopic appendicectomy with standard three-port laparoscopic appendicectomy in adult patients at six weeks post-surgery. We also wish to assess the feasibility of a multicentre randomised controlled trial comparing single port/incision laparoscopic surgery with standard three-port laparoscopic surgery for other surgical techniques. Methods and design: Patients diagnosed with suspected appendicitis and requiring surgical treatment will be randomised to receive either standard three-port or single incision laparoscopic surgery. Data will be collected from clinical notes, operation notes and patient reported questionnaires. The following outcomes will be considered: 1. Effectiveness of the surgical procedure in terms of: • patient reported outcomes • clinical outcomes • resource use 2. Feasibility of conducting a randomised controlled trial (RCT) in the emergency surgical setting by quantifying: • patient eligibility • randomisation acceptability • feasibility of blinding participants to the intervention received • completion rates of case report forms and patient reported questionnaires Trial registration: ISRCTN66443895 (assigned 10 March 2011, first patient randomised 09 January 2011) [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
22. Using a business model approach and marketing techniques for recruitment to clinical trials.
- Author
-
McDonald, Alison M., Treweek, Shaun, Shakur, Haleema, Free, Caroline, Knight, Rosemary, Speed, Chris, and Campbell, Marion K.
- Subjects
- *
RANDOMIZED controlled trials , *MEDICAL care , *BUSINESS planning , *MEDICAL experimentation on humans , *INDUSTRIAL management - Abstract
Randomised controlled trials (RCTs) are generally regarded as the gold standard for evaluating health care interventions. The level of uncertainty around a trial's estimate of effect is, however, frequently linked to how successful the trial has been in recruiting and retaining participants. As recruitment is often slower or more difficult than expected, with many trials failing to reach their target sample size within the timescale and funding originally envisaged, the results are often less reliable than they could have been. The high number of trials that require an extension to the recruitment period in order to reach the required sample size potentially delays the introduction of more effective therapies into routine clinical practice. Moreover, it may result in less research being undertaken as resources are redirected to extending existing trials rather than funding additional studies. Poor recruitment to publicly-funded RCTs has been much debated but there remains remarkably little clear evidence as to why many trials fail to recruit well, which recruitment methods work, in which populations and settings and for what type of intervention. One proposed solution to improving recruitment and retention is to adopt methodology from the business world to inform and structure trial management techniques. We review what is known about interventions to improve recruitment to trials. We describe a proposed business approach to trials and discuss the implementation of using a business model, using insights gained from three case studies. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
23. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial.
- Author
-
Azuara-Blanco, Augusto, Burr, Jennifer M, Cochran, Claire, Ramsay, Craig, Vale, Luke, Foster, Paul, Friedman, David, Quayyum, Zahidul, Lai, Jimmy, Nolan, Winnie, Aung, Tin, Chew, Paul, McPherson, Gladys, McDonald, Alison, Norrie, John, and Effectiveness in Angle-closure Glaucoma of Lens Extraction (EAGLE) Study Group
- Subjects
CLINICAL medicine research ,INTRAOCULAR lenses ,GLAUCOMA diagnosis ,ARTIFICIAL implants ,OPHTHALMIC lenses - Abstract
Background: Glaucoma is the leading cause of irreversible blindness. Although primary open-angle glaucoma is more common, primary angle-closure glaucoma (PACG) is more likely to result in irreversible blindness. By 2020, 5·3 million people worldwide will be blind because of PACG. The current standard care for PACG is a stepped approach of a combination of laser iridotomy surgery (to open the drainage angle) and medical treatment (to reduce intraocular pressure). If these treatments fail, glaucoma surgery (eg, trabeculectomy) is indicated. It has been proposed that, because the lens of the eye plays a major role in the mechanisms leading to PACG, early clear lens extraction will improve glaucoma control by opening the drainage angle. This procedure might reduce the need for drugs and glaucoma surgery, maintain good visual acuity, and improve quality of life compared with standard care.EAGLE aims to evaluate whether early lens extraction improves patient-reported, clinical outcomes, and cost-effectiveness, compared with standard care.Methods/design: EAGLE is a multicentre pragmatic randomized trial. All people presenting to the recruitment centres in the UK and east Asia with newly diagnosed PACG and who are at least 50 years old are eligible.The primary outcomes are EQ-5D, intraocular pressure, and incremental cost per quality adjusted life year (QALY) gained. Other outcomes are: vision and glaucoma-specific patient-reported outcomes, visual acuity, visual field, angle closure, number of medications, additional surgery (e.g., trabeculectomy), costs to the health services and patients, and adverse events.A single main analysis will be done at the end of the trial, after three years of follow-up. The analysis will be based on all participants as randomized (intention to treat). 400 participants (200 in each group) will be recruited, to have 90% power at 5% significance level to detect a difference in EQ-5D score between the two groups of 0·05, and a mean difference in intraocular pressure of 1·75 mm Hg. The study will have 80% power to detect a difference of 15% in the glaucoma surgery rate.Trial Registration: ISRCTN44464607. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
24. Simple imputation methods were inadequate for missing not at random (MNAR) quality of life data.
- Author
-
Fielding, Shona, Fayers, Peter M., McDonald, Alison, McPherson, Gladys, and Campbell, Marion K.
- Subjects
MISSING data (Statistics) ,QUALITY of life ,HEALTH status indicators ,RANDOMIZED controlled trials ,LOGISTIC regression analysis - Abstract
Objective: QoL data were routinely collected in a randomised controlled trial (RCT), which employed a reminder system, retrieving about 50% of data originally missing. The objective was to use this unique feature to evaluate possible missingness mechanisms and to assess the accuracy of simple imputation methods. Methods: Those patients responding after reminder were regarded as providing missing responses. A hypothesis test and a logistic regression approach were used to evaluate the missingness mechanism. Simple imputation procedures were carried out on these missing scores and the results compared to the actual observed scores. Results: The hypothesis test and logistic regression approaches suggested the reminder data were missing not at random (MNAR). Reminder-response data showed that simple imputation procedures utilising information collected close to the point of imputation (last value carried forward, next value carried backward and last-and-next), were the best methods in this setting. However, although these methods were the best of the simple imputation procedures considered, they were not sufficiently accurate to be confident of obtaining unbiased results under imputation. Conclusion: The use of the reminder data enabled the conclusion of possible MNAR data. Evaluating this mechanism was important in determining if imputation was useful. Simple imputation was shown to be inadequate if MNAR are likely and alternative strategies should be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
25. Marketing and clinical trials: a case study.
- Author
-
Francis, David, Roberts, Ian, Elbourne, Diana R., Shakur, Haleema, Knight, Rosemary C., Garcia, Jo, Snowdon, Claire, Entwistle, Vikki A., McDonald, Alison M., Grant, Adrian M., and Campbell, Marion K.
- Subjects
CLINICAL medicine ,MEDICAL research ,MEDICAL experimentation on humans ,CLINICAL trials ,CASE studies ,CLINICAL pharmacology ,THERAPEUTICS - Abstract
Background: Publicly funded clinical trials require a substantial commitment of time and money. To ensure that sufficient numbers of patients are recruited it is essential that they address important questions in a rigorous manner and are managed well, adopting effective marketing strategies. Methods: Using methods of analysis drawn from management studies, this paper presents a structured assessment framework or reference model, derived from a case analysis of the MRC's CRASH trial, of 12 factors that may affect the success of the marketing and sales activities associated with clinical trials. Results: The case study demonstrates that trials need various categories of people to buy in -- hence, to be successful, trialists must embrace marketing strategies to some extent. Conclusion: The performance of future clinical trials could be enhanced if trialists routinely considered these factors. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
26. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies.
- Author
-
McDonald, Alison M., Knight, Rosemary C., Campbell, Marion K., Entwistle, Vikki A., Grant, Adrian M., Cook, Jonathan A., Elbourne, Diana R., Francis, David, Garcia, Jo, Roberts, Ian, and Snowdon, Claire
- Subjects
- *
MEDICAL research , *MEDICAL technology , *CHI-squared test , *STATISTICAL hypothesis testing , *CLINICAL trials - Abstract
Background: A commonly reported problem with the conduct of multicentre randomised controlled trials (RCTs) is that recruitment is often slower or more difficult than expected, with many trials failing to reach their planned sample size within the timescale and funding originally envisaged. The aim of this study was to explore factors that may have been associated with good and poor recruitment in a cohort of multicentre trials funded by two public bodies: the UK Medical Research Council (MRC) and the Health Technology Assessment (HTA) Programme. Methods: The cohort of trials was identified from the administrative databases held by the two funding bodies. 114 trials that recruited participants between 1994 and 2002 met the inclusion criteria. The full scientific applications and subsequent trial reports submitted by the trial teams to the funders provided the principal data sources. Associations between trial characteristics and recruitment success were tested using the Chi-squared test, or Fisher's exact test where appropriate. Results: Less than a third (31%) of the trials achieved their original recruitment target and half (53%) were awarded an extension. The proportion achieving targets did not appear to improve over time. The overall start to recruitment was delayed in 47 (41%) trials and early recruitment problems were identified in 77 (63%) trials. The inter-relationship between trial features and recruitment success was complex. A variety of strategies were employed to try to increase recruitment, but their success could not be assessed. Conclusion: Recruitment problems are complex and challenging. Many of the trials in the cohort experienced recruitment difficulties. Trials often required extended recruitment periods (sometimes supported by additional funds). While this is of continuing concern, success in addressing the trial question may be more important than recruitment alone. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
27. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
- Author
-
Mitchell, Eleanor J., Ahmed, Khaled, Breeman, Suzanne, Cotton, Seonaidh, Constable, Lynda, Ferry, Gillian, Goodman, Kirsteen, Hickey, Helen, Meakin, Garry, Mironov, Katy, Quann, Niamh, Wakefield, Natalie, and McDonald, Alison
- Subjects
COVID-19 pandemic ,EXPERIMENTAL design ,PANDEMICS ,COVID-19 - Abstract
The COVID-19 pandemic has presented unique challenges for the clinical trial community, both in the rapid establishment of COVID-19 clinical trials and many existing non-COVID-19 studies either being temporarily paused (whether that is a complete pause or pause in some activities) and/or adapting their processes. Trial managers have played a key role in decision-making, undertaking risk assessments and adapting trial processes, working closely with other members of the research team. This article presents some of the ways in which trial management processes have been altered and the key role that trial managers have played. It has been born out of discussions between trial managers in the UK who are members of the UK Trial Managers' Network (UKTMN), a national network of trial management professionals managing non-commercial trials.In these unprecedented times, clinical trials have faced many uncertainties and broad-ranging challenges encompassing a range of activities including prioritising patient safety amidst the pandemic, consenting and recruiting new participants into trials, data collection and management and intervention delivery. In many cases, recruitment has been paused whilst mitigations have been put in place to continue data collection. Innovative solutions have been implemented to ensure we continue, where possible, to deliver high-quality clinical trials. Technology has provided many solutions to these challenges, and trial managers have adapted to new ways of working whilst continuing to deliver their clinical trials. Trial management groups are now faced with new uncertainties around re-starting clinical trials, and it is unclear currently how this will go, though working together with sponsors, funders and site teams is clearly a priority.Clinical trial teams have worked together to ensure their trials have adapted quickly whilst ensuring participant safety is given utmost importance. There are clear examples where the trial community have come together to share experiences and expertise, and this should continue in the future to ensure the innovative practices developed become embedded in the design and conduct of clinical trials in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
28. Advance telephone calls ahead of reminder questionnaires increase response rate in non-responders compared to questionnaire reminders only: The RECORD phone trial.
- Author
-
Maclennan, Graeme, McDonald, Alison, McPherson, Gladys, Treweek, Shaun, Avenell, Alison, and RECORD Trial Group
- Abstract
Background: Postal questionnaires are simple and economical for collecting outcome data for randomised controlled trials (RCTs) but are prone to non-response. In the RECORD trial (a large pragmatic publicly funded RCT in UK) non-responders were sent a reminder and another questionnaire at 1 year, of which 40% were returned. In subsequent years we investigated the effect of an advance telephone call to non-responders on responses rate to reminder questionnaires and the next questionnaire 4 months later.Methods: Non-responders to annual questionnaires were randomised to receive a telephone call from the trial office ahead of the reminder questionnaire in addition to the usual reminder schedule (n=390) or to a control group that received the usual reminder schedule only (n=363). The primary outcome was response to the reminder questionnaire within 21 days; secondary outcomes were response to a questionnaire 4 months later; completeness of quality of life instruments; and the number of participants declining further follow-up. Results are presented as odds ratios from a logistic regression intention-to-treat (ITT) analysis and then percentage difference and 95% confidence intervals (CI) for both ITT and average treatment effect on the treated (ATT) analyses.Results: The proportions that responded were 67.8% (265/390) in the intervention group compared to 62.5% (227/363) in the control group. The ITT estimate was a 5.4% increase (95% CI -1.4 to 12.2). Four months later percentages responding were 51.8% (202) and 42.7% (155). The ITT estimate was a 9.1% increase (95% CI 2.0 to 16.2). In the intervention group 12.3% (48/390) of participants were not telephoned because questionnaires were returned before the scheduled telephone call. ATT estimates adjusting for this were 6.2% (95% CI -1.6 to 14.0) and 10.4% (95% CI 2.2 to 18.5), respectively.Conclusions: The telephone call resulted in a slight increase in response to the reminder questionnaire, however at 4 months later the proportion in the telephoned group responding was greater. This study suggests that pre-notification telephone calls may only be worthwhile if further questionnaires are to be sent out soon after reminder questionnaires.Trial Registration: Current Clinical Trials ISRCTN51647438. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
29. Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin): study protocol for a randomized controlled trial.
- Author
-
McClinton, Sam, Starr, Kathryn, Thomas, Ruth, McLennan, Graeme, McPherson, Gladys, McDonald, Alison, Lam, Thomas, N'Dow, James, Kilonzo, Mary, Pickard, Robert, Anson, Ken, Burr, Jennifer, and SUSPEND Study Group
- Abstract
Background: Urinary stone disease is common, with an estimated prevalence among the general population of 2% to 3%. Ureteric stones can cause severe pain and have a significant impact on quality of life, accounting for over 15,000 hospital admissions in England annually. Uncomplicated cases of smaller stones in the lower ureter are traditionally treated expectantly. Those who fail standard care or develop complications undergo active treatment, such as extracorporeal shock wave lithotripsy or ureteroscopy with stone retrieval. Such interventions are expensive, require urological expertise and carry a risk of complications.Growing understanding of ureteric function and pathophysiology has led to the hypothesis that drugs causing relaxation of ureteric smooth muscle, such as the selective α-blocker tamsulosin and the calcium-channel blocker nifedipine, can enhance the spontaneous passage of ureteric stones. The use of drugs in augmenting stone passage, reducing the morbidity and costs associated with ureteric stone disease, is promising. However, the majority of clinical trials conducted to date have been small, poor to moderate quality and lacking in comprehensive economic evaluation.This trial aims to determine the clinical and cost-effectiveness of tamsulosin and nifedipine in the management of symptomatic urinary stones.Methods/design: The SUSPEND (Spontaneous Urinary Stone Passage ENabled by Drugs) trial is a multicentre, double-blind, randomized controlled trial evaluating two medical expulsive therapy strategies (nifedipine or tamsulosin) versus placebo.Patients aged 18 to 65 with a ureteric stone confirmed by non-contrast computed tomography of the kidney, ureter and bladder will be randomized to receive nifedipine, tamsulosin or placebo (400 participants per arm) for a maximum of 28 days. The primary clinical outcome is spontaneous passage of ureteric stones at 4 weeks (defined as no further intervention required to facilitate stone passage). The primary economic outcome is a reduction in the incremental cost per quality-adjusted life years, determined at 12 weeks. The analysis will be based on all participants as randomized (intention to treat). The trial has 90% power with a type I error rate of 5% to detect a 10% increase in primary outcome between the tamsulosin and nifedipine treatment groups.Trial Registration: ISRCTN69423238; EudraCT number: 2010-019469-26. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
30. Patient reported clinical outcomes: the challenges and implications for randomised controlled trials.
- Author
-
Breeman, Suzanne, McDonald, Alison, McPherson, Gladys, MacLennan, Graeme, Campbell, Marion, Starr, Kath, and Cotton, Seonaidh
- Subjects
- *
RANDOMIZED controlled trials , *HEALTH outcome assessment - Abstract
An abstract of the article "Patient reported clinical outcomes: the challenges and implications for randomised controlled trials," by Suzanne Breeman and colleagues, is presented.
- Published
- 2011
- Full Text
- View/download PDF
31. Clinical and cost-effectiveness of internal limiting membrane peeling for patients with idiopathic full thickness macular hole. Protocol for a randomised controlled trial: FILMS (Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study).
- Author
-
Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group, Lois, Noemi, Burr, Jennifer, Norrie, John, Vale, Luke, Cook, Jonathan, and McDonald, Alison
- Abstract
Background: A full-thickness macular hole (FTMH) is a common retinal condition associated with impaired vision. Randomised controlled trials (RCTs) have demonstrated that surgery, by means of pars plana vitrectomy and post-operative intraocular tamponade with gas, is effective for stage 2, 3 and 4 FTMH. Internal limiting membrane (ILM) peeling has been introduced as an additional surgical manoeuvre to increase the success of the surgery; i.e. increase rates of hole closure and visual improvement. However, little robust evidence exists supporting the superiority of ILM peeling compared with no-peeling techniques. The purpose of FILMS (Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study) is to determine whether ILM peeling improves the visual function, the anatomical closure of FTMH, and the quality of life of patients affected by this disorder, and the cost-effectiveness of the surgery.Methods/design: Patients with stage 2-3 idiopathic FTMH of less or equal than 18 months duration (based on symptoms reported by the participant) and with a visual acuity = 20/40 in the study eye will be enrolled in this FILMS from eight sites across the UK and Ireland. Participants will be randomised to receive combined cataract surgery (phacoemulsification and intraocular lens implantation) and pars plana vitrectomy with postoperative intraocular tamponade with gas, with or without ILM peeling. The primary outcome is distance visual acuity at 6 months. Secondary outcomes include distance visual acuity at 3 and 24 months, near visual acuity at 3, 6, and 24 months, contrast sensitivity at 6 months, reading speed at 6 months, anatomical closure of the macular hole at each time point (1, 3, 6, and 24 months), health related quality of life (HRQOL) at six months, costs to the health service and the participant, incremental costs per quality adjusted life year (QALY) and adverse events.Discussion: FILMS will provide high quality evidence on the role of ILM peeling in FTMH surgery.Trial Registration: This trial is registered with Current Controlled Trials ISRCTN number 33175422 and Clinical Trials.gov identifier NCT00286507. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
32. Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.
- Author
-
Treweek S, Altman DG, Bower P, Campbell M, Chalmers I, Cotton S, Craig P, Crosby D, Davidson P, Devane D, Duley L, Dunn J, Elbourne D, Farrell B, Gamble C, Gillies K, Hood K, Lang T, Littleford R, Loudon K, McDonald A, McPherson G, Nelson A, Norrie J, Ramsay C, Sandercock P, Shanahan DR, Summerskill W, Sydes M, Williamson P, and Clarke M
- Subjects
- Access to Information, Cooperative Behavior, Efficiency, Evidence-Based Medicine organization & administration, Humans, Information Dissemination, Interdisciplinary Communication, International Cooperation, Efficiency, Organizational, Evidence-Based Medicine methods, Randomized Controlled Trials as Topic methods, Research Design
- Abstract
Randomised trials are at the heart of evidence-based healthcare, but the methods and infrastructure for conducting these sometimes complex studies are largely evidence free. Trial Forge ( www.trialforge.org ) is an initiative that aims to increase the evidence base for trial decision making and, in doing so, to improve trial efficiency.This paper summarises a one-day workshop held in Edinburgh on 10 July 2014 to discuss Trial Forge and how to advance this initiative. We first outline the problem of inefficiency in randomised trials and go on to describe Trial Forge. We present participants' views on the processes in the life of a randomised trial that should be covered by Trial Forge.General support existed at the workshop for the Trial Forge approach to increase the evidence base for making randomised trial decisions and for improving trial efficiency. Agreed upon key processes included choosing the right research question; logistical planning for delivery, training of staff, recruitment, and retention; data management and dissemination; and close down. The process of linking to existing initiatives where possible was considered crucial. Trial Forge will not be a guideline or a checklist but a 'go to' website for research on randomised trials methods, with a linked programme of applied methodology research, coupled to an effective evidence-dissemination process. Moreover, it will support an informal network of interested trialists who meet virtually (online) and occasionally in person to build capacity and knowledge in the design and conduct of efficient randomised trials.Some of the resources invested in randomised trials are wasted because of limited evidence upon which to base many aspects of design, conduct, analysis, and reporting of clinical trials. Trial Forge will help to address this lack of evidence.
- Published
- 2015
- Full Text
- View/download PDF
33. IQuaD dental trial; improving the quality of dentistry: a multicentre randomised controlled trial comparing oral hygiene advice and periodontal instrumentation for the prevention and management of periodontal disease in dentate adults attending dental primary care.
- Author
-
Clarkson JE, Ramsay CR, Averley P, Bonetti D, Boyers D, Campbell L, Chadwick GR, Duncan A, Elders A, Gouick J, Hall AF, Heasman L, Heasman PA, Hodge PJ, Jones C, Laird M, Lamont TJ, Lovelock LA, Madden I, McCombes W, McCracken GI, McDonald AM, McPherson G, Macpherson LE, Mitchell FE, Norrie JD, Pitts NB, van der Pol M, Ricketts DNj, Ross MK, Steele JG, Swan M, Tickle M, Watt PD, Worthington HV, and Young L
- Subjects
- Adult, Aged, Dental Calculus prevention & control, Dental Care economics, Dental Plaque prevention & control, Dental Prophylaxis economics, Dental Prophylaxis standards, Follow-Up Studies, Gingival Hemorrhage prevention & control, Gingivitis prevention & control, Health Behavior, Health Knowledge, Attitudes, Practice, Humans, Middle Aged, Oral Hygiene economics, Periodontal Pocket prevention & control, Periodontitis prevention & control, Precision Medicine, Quality of Life, Self Care, Self Efficacy, Single-Blind Method, Toothbrushing methods, Treatment Outcome, Counseling, Dental Care standards, Oral Hygiene education, Periodontal Diseases prevention & control, Primary Health Care standards, Quality of Health Care
- Abstract
Background: Periodontal disease is the most common oral disease affecting adults, and although it is largely preventable it remains the major cause of poor oral health worldwide. Accumulation of microbial dental plaque is the primary aetiological factor for both periodontal disease and caries. Effective self-care (tooth brushing and interdental aids) for plaque control and removal of risk factors such as calculus, which can only be removed by periodontal instrumentation (PI), are considered necessary to prevent and treat periodontal disease thereby maintaining periodontal health. Despite evidence of an association between sustained, good oral hygiene and a low incidence of periodontal disease and caries in adults there is a lack of strong and reliable evidence to inform clinicians of the relative effectiveness (if any) of different types of Oral Hygiene Advice (OHA). The evidence to inform clinicians of the effectiveness and optimal frequency of PI is also mixed. There is therefore an urgent need to assess the relative effectiveness of OHA and PI in a robust, sufficiently powered randomised controlled trial (RCT) in primary dental care., Methods/design: This is a 5 year multi-centre, randomised, open trial with blinded outcome evaluation based in dental primary care in Scotland and the North East of England. Practitioners will recruit 1860 adult patients, with periodontal health, gingivitis or moderate periodontitis (Basic Periodontal Examination Score 0-3). Dental practices will be cluster randomised to provide routine OHA or Personalised OHA. To test the effects of PI each individual patient participant will be randomised to one of three groups: no PI, 6 monthly PI (current practice), or 12 monthly PI.Baseline measures and outcome data (during a three year follow-up) will be assessed through clinical examination, patient questionnaires and NHS databases.The primary outcome measures at 3 year follow up are gingival inflammation/bleeding on probing at the gingival margin; oral hygiene self-efficacy and net benefits., Discussion: IQuaD will provide evidence for the most clinically-effective and cost-effective approach to managing periodontal disease in dentate adults in Primary Care. This will support general dental practitioners and patients in treatment decision making., Trial Registration: Protocol ID: ISRCTN56465715.
- Published
- 2013
- Full Text
- View/download PDF
34. Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study.
- Author
-
Snowdon C, Elbourne DR, Garcia J, Campbell MK, Entwistle VA, Francis D, Grant AM, Knight RC, McDonald AM, and Roberts I
- Abstract
Background: Securing and managing finances for multicentre randomised controlled trials is a highly complex activity which is rarely considered in the research literature. This paper describes the process of financial negotiation and the impact of financial considerations in four UK multicentre trials. These trials had met, or were on schedule to meet, recruitment targets agreed with their public-sector funders. The trials were considered within a larger study examining factors which might be associated with trial recruitment (STEPS)., Methods: In-depth semi-structured telephone interviews were conducted in 2003-04 with 45 individuals with various responsibilities to one of the four trials. Interviewees were recruited through purposive and then snowball sampling. Interview transcripts were analysed with the assistance of the qualitative package Atlas-ti., Results: The data suggest that the UK system of dividing funds into research, treatment and NHS support costs brought the trial teams into complicated negotiations with multiple funders. The divisions were somewhat malleable and the funding system was used differently in each trial. The fact that all funders had the potential to influence and shape the trials considered here was an important issue as the perspectives of applicants and funders could diverge. The extent and range of industry involvement in non-industry-led trials was striking. Three broad periods of financial work (foundation, maintenance, and resourcing completion) were identified. From development to completion of a trial, the trialists had to be resourceful and flexible, adapting to changing internal and external circumstances. In each period, trialists and collaborators could face changing costs and challenges. Each trial extended the recruitment period; three required funding extensions from MRC or HTA., Conclusion: This study highlights complex financial aspects of planning and conducting trials, especially where multiple funders are involved. Recognition of the importance of financial stability and of the need for appropriate training in this area should be paralleled by further similar research with a broader range of trials, aimed at understanding and facilitating the conduct of clinical research.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.